Skip to main content
Ovation Science Inc. logo

Ovation Science Inc. — Investor Relations & Filings

Ticker · OVAT ISIN · CA69016D1087 LEI · 549300A1P7L8HTTQXY56 CSE Professional, scientific and technical activities
Filings indexed 252 across all filing types
Latest filing 2020-03-19 Regulatory Filings
Country CA Canada
Listing CSE OVAT

About Ovation Science Inc.

https://ovationscience.com/

Ovation Science Inc. is a research and development company specializing in advanced topical and transdermal product formulations. The core technology is Invisicare®, a patented, high-performance drug delivery system engineered to enhance the penetration and efficacy of active ingredients, particularly cannabis and hemp-derived cannabinoids (CBD, THC, CBN, CBG). Ovation utilizes pharmaceutical protocols to develop these formulations. Its primary business model involves licensing the Invisicare® technology and proprietary formulations to international partners for manufacturing and market distribution. The company also distributes finished topical CBD products under proprietary brands, such as the Invibe® MD wellness line and ARLO CBD Beauty anti-aging line, all leveraging the unique delivery capabilities of Invisicare®.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Ovation Science has increased manufacturing of its DermSafe hand sanitizer in response to Health Canada's regulatory changes to facilitate supply during the COVID-19 pandemic. It contains no financial data, no regulatory filings, no voting results, no management or board changes, no earnings or annual report information. It is a corporate announcement about operational activity related to product supply and regulatory environment. The document length is 4621 characters, which is relatively short and reads like a news or business update rather than a formal financial or regulatory filing. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The closest fitting category is Regulatory Filings (RNS) as a general regulatory announcement or corporate update that does not fit other specific categories.
2020-03-19 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing increased shipments of a product (DermSafe hand sanitizer lotion) due to COVID-19 demand. It contains no financial data, no regulatory filing references, no meeting or voting information, no audit or management reports, and no mention of any report publication or certification. It is a business update focused on product demand and shipment activity. This type of document fits best under Regulatory Filings (RNS) as a general regulatory announcement or business update that does not fit other specific categories.
2020-03-17 English
News release - English.pdf
Regulatory Filings
2020-03-12 English
News release - English.pdf
Regulatory Filings
2020-03-11 English
News release - English.pdf
Regulatory Filings Classification · 85% confidence The document is a press release announcing the shipment of a product (DermSafe hand sanitizer lotion) to China, highlighting the company's first international sale and product details. It includes forward-looking statements and contact information for investor relations and business development. There is no financial data, regulatory filing references, or detailed report content. The document is a corporate announcement about a business development or product shipment, not a financial report, regulatory filing, or management report. It does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. The closest fitting category is Capital/Financing Update (CAP) since it relates to a business milestone and sales activity, but it is more of a general corporate announcement. However, since CAP is specifically for fundraising or capital structure changes, and this is a product shipment announcement, the best fit is Regulatory Filings (RNS) as a fallback for miscellaneous corporate announcements that do not fit other categories.
2020-02-27 English
News release - English.pdf
Regulatory Filings
2020-02-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.